NCT05968196 (HCC and FTC) is a clinical trial in Huerthle Cell Carcinoma, sponsored by The Catholic University of Korea.

Who is sponsoring NCT05968196?

NCT05968196 is sponsored by The Catholic University of Korea.

What condition does NCT05968196 study?

NCT05968196 studies Huerthle Cell Carcinoma.

Is NCT05968196 still recruiting?

NCT05968196 is currently completed. Last updated 1 August 2023.

Last reviewed 2023-08-01 · How we verify

NCT05968196: HCC and FTC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

Completed Last updated 1 August 2023

What this trial tests

trial in Huerthle Cell Carcinoma in 221 participants. Completed in 31 March 2023.

Timeline

1 January 2000

Primary endpoint
31 December 2020

31 March 2023

Quick facts

Lead sponsor	The Catholic University of Korea
Status	Completed
Study type	OBSERVATIONAL
Enrollment	221
Start date	1 January 2000
Primary completion	31 December 2020
Estimated completion	31 March 2023

Conditions studied

Huerthle Cell Carcinoma — all drugs for Huerthle Cell Carcinoma →

Sponsor

The Catholic University of Korea

Who can join

Eligibility, any sex, with Huerthle Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this retrospective study is to evaluate in patients with HCC and FTC who underwent lobectomy. The main questions it aims to answer are: * The necessity of completion thyroidectomy based on the clinicopathological characteristics * Prognosis Participants underwent thyroid lobectomy Researchers compared HCC and FTC groups to see the prognosis after lobectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other The Catholic University of Korea trials

Trials by the same sponsor.

NCT06367998 — Effect of Pregabalin on Shoulder Pain in Patients With Central Sensitization After Arthroscopic Rotator Cuff Repair · Phase 4 · not yet recruiting
NCT07174544 — Mobile Self-Management Program for Stress Reduction in Young Adults · NA · completed
NCT05671705 — Effect of Sarcopenia in Stroke Patients · completed
NCT05509244 — Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Laparoscopic Gynecology Surgery · NA · unknown
NCT05539690 — Effect of Balance Training on White Matter Tracts in Healthy Elderly Population · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05968196 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Catholic University of Korea
Last refreshed: 1 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05968196.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing